Logo-apb

Journal Info:

Freq.: Quarterly

eISSN: 2251-7308 
pISSN: 2228-5881 

Permission: CC By

Platinum Open Access

(no submission or publication fees)

Powered by
Adv Pharm Bull. 2022;12(4): 763-771. doi: 10.34172/apb.2022.078
PMID: 36415627        PMCID: PMC9675932

Mini Review

Nanostructured Lipid Carriers for Nose to Brain Delivery TargetingCNS: Diversified Role of Liquid Lipids for Synergistic Action

Avinash Ramrao Tekade 1 * ORCID, Pradeep Sadanand Mittha 1, Charushila Sopan Pisal 1

Cited by CrossRef: 3

1- Khare S, Kushwaha S, Mishra A. Optimized Lacosamide Nanostructured Lipid Carriers for Enhanced Brain Targeting Via the Intranasal Route. J Pharm Innov. 2025;20(6) [Crossref]
2- Patel S, Shah Y, Patel V, Patel A, Panjwani D, Ahlawat P. Formulation and ex vivo characterization of lipid-coated clozapine albumin nanoparticles for intranasal delivery in schizophrenia management. Journal of Dispersion Science and Technology. 2025;:1 [Crossref]
3- Das M, Sarma A, Baruah H, Basak D. Insight into central nervous system targeted nanostructured lipid carriers via the nose to brain pathway. RSC Pharm. 2024;1(5):904 [Crossref]
4- Shahraki O, Nabavinia M, Tiba A, Daneshmand S. Piperine and Lavender Oil Enriched Nanostructured Lipid Carriers to Inhibit Staphylococcus aureus Biofilm. Jundishapur J Nat Pharm Prod. 2025;20(1) [Crossref]
5- Cheng K, Zhao H, He K, Xia X, Wang Y, Wang S, Li W. Progress, critical challenges, and translational prospects of intranasal administration of botanical essential oils for the treatment of depression. Front Pharmacol. 2026;16 [Crossref]
6- Zheng B, Liu D, Qin X, Zhang D, Zhang P. Mucoadhesive-to-Mucopenetrating Nanoparticles for Mucosal Drug Delivery: A Mini Review. IJN. 2025;Volume 20:2241 [Crossref]
7- Shah S, Patel A, Prajapati B, Alexander A, Pandya V, Trivedi N, Pandey P, Patel S, Patel R. Multifaceted nanolipidic carriers: a modish stratagem accentuating nose-to-brain drug delivery. J Nanopart Res. 2023;25(7) [Crossref]
8- Padti A, Bhavi S, Thokchom B, Singh S, Bhat S, Harini B, Sillanpää M, Yarajarla R. Nanoparticle Interactions with the Blood Brain Barrier: Insights from Drosophila and Implications for Human Astrocyte Targeted Therapies. Neurochem Res. 2025;50(1) [Crossref]
9- Kumbhar P, Kolekar K, Vishwas S, Kamble V, Bashir B, Patil K, Bhagwat D, Gupta G, Prasher P, Singh M, Singh S, Disouza J, Patravale V. Plant-based flavonoids and their nanoparticles: Latest arsenal against Alzheimer’s disease. Drug Deliv and Transl Res. 2025;15(12):4411 [Crossref]
10- Sartaj A, Nabi B, Iqubal A, Aggarwal N, Haider K, Baboota S, Ali J. Development and Characterization of Oral Efavirenz-Loaded Nanostructured Lipid Carriers and Their Optimization with Box–Behnken Design Approach for the Neurological Disorder. ASSAY and Drug Development Technologies. 2025;23(2):84 [Crossref]
11- Chaudhri N, Rastogi V, Verma A. A Review on Lipid-based Nanoformulations for Targeting Brain through Non-invasive Nasal Route. PNT. 2025;13(1):143 [Crossref]